Ligand · VY3
VY3 · ~{N}-[2-[2-[2-[2-[2-[2-[3-[4-[4-(2-azanylethylamino)-2-[1-(4-chlorophenyl)cyclopentyl]quinazolin-7-yl]piperazin-1-yl]-3-oxidanylidene-propoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]ethanamide
VY3, ~{N}-[2-[2-[2-[2-[2-[2-[3-[4-[4-(2-azanylethylamino)-2-[1-(4-chlorophenyl)cyclopentyl]quinazolin-7-yl]piperazin-1-yl]-3-oxidanylidene-propoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]ethanamide (C42 H62 Cl N7 O8, 828.4 g/mol), in the…
- Component
- VY3
- Formula
- C42 H62 Cl N7 O8
- Class
- ligand
- Structures
- 1
- PDB entries
- 1
Binding sites
VY3 in 1 structure; the first of them:
- 8OOD · Crystal structure of human DCAF1 WD40 repeats (Q1250L) in complex with compound 15 · VY3 A1509 · binds THR1097, CYS1098, ALA1137, ILE1138, THR1139, HIS1140, THR1155, TRP1156 and 13 more
Residues it binds most
PHE 2, ARG 2, LEU 2, THR 1, ALA 2, CYS 1, HIS 1, ILE 1, LYS 2, MET 2 (residue and the binding sites it lines).
Found with
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.